Taskus Inc
NASDAQ:TASK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Taskus Inc
NASDAQ:TASK
|
US |
|
Klepierre SA
PAR:LI
|
FR |
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
M
|
Medifast Inc
XMUN:MDF
|
US |
|
W
|
Wesco International Inc
XMUN:WP7
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
I
|
IMPACT Growth Real Estate Investment Trust
SET:IMPACT
|
TH |
|
E
|
Extra Space Storage Inc
F:FG8
|
US |
|
S
|
Swedish Match AB
F:SWMC
|
SE |
|
Arvind Ltd
BSE:500101
|
IN |
|
A
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMIRT
|
TH |
Wall St Price Targets
TASK Price Targets Summary
Taskus Inc
According to Wall Street analysts, the average 1-year price target for TASK is 9.79 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TASK's stock price target?
Price Target
9.79
USD
According to Wall Street analysts, the average 1-year price target for TASK is 9.79 USD with a low forecast of 6.06 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for Taskus Inc?
Projected CAGR
8%
Over the last 6 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 5 years is 8%.
What is the Operating Income forecast for Taskus Inc?
Projected CAGR
15%
Over the last 6 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 5 years is 15%.
What is the Net Income forecast for Taskus Inc?
Projected CAGR
19%
Over the last 6 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 5 years is 19%.
